UNSPSC 51172119: Butaverine

This classification denotes an antispasmotic agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 1I5O5WIU8X. European Medicines Agency schedules Butaverine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06009MIG. Butaverine generally arises in the molecular formula C18H27NO2.

The term BUTAVERINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 19 1975, list 5.) BUTAVERINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule butaverine under HS 29333999 and SITC 51574. As of Q4 2014, BUTAVERINE remains the US FDA Preferred Term for this commodity. Butaverine bears US NLM identifiers UMLS ID C0771071 and NCI Concept Code C73169. SMILES: O(C(=O)CC(N1CCCCC1)C1CCCCC1)CCCC.

UNSPSC 51172119 Butaverine is a Commodity code that in recent state and local solicitation activity maps to offender drug-testing services, including specimen collection, immunoassay screening with confirmatory testing (LC/MS/MS or GC/MS), and alternative methodologies such as oral fluid and hair testing. The code's abstract pharmaceutical framing does not align with the actual scope of work being bought; state and local procurement offices are soliciting testing services and lab operations rather than the butaverine pharmaceutical itself. Issuing bodies under this code include county criminal-justice and community-supervision departments. Collin County Community Supervision and Corrections Department, located in north Texas, recently issued RFP 2026-327 for offender specimen collection and drug testing services, with an estimated contract value of $600,000 over an initial two-year term and up to three optional one-year renewals. The scope encompasses staffing two collection sites in Plano and McKinney during weekday business hours and five Saturdays annually, operating an Interactive Voice Response system for randomized testing notifications, and delivering approximately 25,031 tests annually across five-panel, six-panel, and ancillary screening protocols.

The geographic footprint is limited to north Texas based on recent activity. Collin County's RFP 2026-327 closed with a due date of July 23, 2026 and an anticipated award date of August 10, 2026; the successful vendor must maintain lab certification from SAMHSA, Texas Department of Public Safety, or the College of American Pathologists. Pricing is structured on a per-test basis across three service models—screening only, confirmation after screening, and screening with automatic confirmation of positives—with all costs including staffing, freight, delivery, and insurance bundled into the per-test rate and no additional surcharges permitted. Evaluation criteria weight vendor understanding at 30 points, firm qualifications at 25 points, client references at 15 points, cost at 30 points, and optional Phase 2 demonstrations and interviews at up to 30 additional points. The county reserves the right to award in whole or in part to multiple vendors. Funding derives from Texas Department of Criminal Justice–Community Justice Assistance Division appropriations, subject to annual availability.